Long-term mortality assessment of multidrug-resistant tuberculosis patients treated with delamanid

MDR-TB patients treated with 6 months or more of delamanid had significantly lower likelihood of mortality http://ow.ly/HOv1d

Detalles Bibliográficos
Autores principales: Wells, Charles D., Gupta, Rajesh, Hittel, Norbert, Geiter, Lawrence J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: European Respiratory Society 2015
Materias:
Agora
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416109/
https://www.ncbi.nlm.nih.gov/pubmed/25700385
http://dx.doi.org/10.1183/09031936.00176314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4416109/
https://www.ncbi.nlm.nih.gov/pubmed/25700385
http://dx.doi.org/10.1183/09031936.00176314

Ejemplares similares